Bayh-Dole Act’s Impact on Drug Prices Sparks Debate at NYU Law Event

An advocate for lowering drug prices debated a former U.S. Patent and Trademark Office director on the potential risks of accepting government funds for drug development. This discussion, held at the New York University School of Law, centered on the implications of the Bayh-Dole Act, which allows for patent rights from federally funded research to be retained by contractors or inventors. The event highlighted contrasting views on how the funding and legal frameworks might affect the pharmaceutical industry. For more detailed insights from the debate, visit the original article.